Clinical Trials Browser

Primary Early-stage Non-small Cell Lung Cancer

NCT07498595 2026-03-27

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Phase EARLY_PHASE1 Not yet recruiting

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07458919 2026-03-09

Therapy for Advanced NSCLC With EGFR 19delins Mutation

Phase EARLY_PHASE1 Not yet recruiting

94 enrolled

Thoracic

Lung Neoplasms

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

Phase EARLY_PHASE1 Not yet recruiting

24 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT05557708 2025-07-08

A Safety Study of 212Pb-Pentixather Radioligand Therapy

Phase EARLY_PHASE1 Not yet recruiting

20 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07007325 2025-06-05

PASSIFLORE

Phase EARLY_PHASE1 Not yet recruiting

15 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06979661 2025-05-20

PORT

Phase EARLY_PHASE1 Not yet recruiting

25 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06756295 2025-03-12

FAST-CR

Phase EARLY_PHASE1 Not yet recruiting

154 enrolled

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT06742099 2024-12-19

The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion

Phase EARLY_PHASE1 Not yet recruiting

20 enrolled

MyeloidThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Pleural Effusion, Malignant

NCT06735508 2024-12-16

MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

Phase EARLY_PHASE1 Not yet recruiting

40 enrolled

Thoracic

NSCLC

NCT06685653 2024-11-12

Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients

Phase EARLY_PHASE1 Not yet recruiting

65 enrolled

Thoracic

NSCLC

NCT06619886 2024-10-01

TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor

Phase EARLY_PHASE1 Not yet recruiting

9 enrolled

GastrointestinalThoracic

Adenocarcinoma of Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT06570538 2024-08-26

Analgesic Efficacy of an Opioid-free Postoperative Pain Management Strategy Versus a Conventional Opioid-based Strategy Following Video-assisted Thoracoscopic Lobectomy

Phase EARLY_PHASE1 Not yet recruiting

140 enrolled

Thoracic

Lung Neoplasms, Pain, Postoperative

NCT06557096 2024-08-16

CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC

Phase EARLY_PHASE1 Not yet recruiting

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Clinical Trials

TILs Therapy for Multiple Primary Early-Stage NSCLC

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Therapy for Advanced NSCLC With EGFR 19delins Mutation

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

A Safety Study of 212Pb-Pentixather Radioligand Therapy

PASSIFLORE

PORT

FAST-CR

The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion

MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients

TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor

Analgesic Efficacy of an Opioid-free Postoperative Pain Management Strategy Versus a Conventional Opioid-based Strategy Following Video-assisted Thoracoscopic Lobectomy

CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC